Loading
Insider filings for Hypha Labs, Inc. are scarce in the SEC (Form 4) feed, the latest one published on 2 December 2024. This page will fill in as new trades are disclosed. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended September 2025 · cache
25 of 46 declarations
Hypha Labs, Inc. is a company listed on the XNAS market. It specializes in developing technological solutions for the healthcare sector.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Sep 2022 | 2.7 m USD | -2.1 m USD | -0.03 USD | 10-K |
| Sep 2021 | 2.5 m USD | -686,503 USD | n.d. | 10-K |
| Sep 2020 | 2.6 m USD | -2.3 m USD | n.d. | 10-K |
| Sep 2019 | 2.6 m USD | -1.8 m USD | n.d. | 10-K |
| Sep 2018 | 2.8 m USD | -1.7 m USD | n.d. | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.